Price$6.65+1.08 (+19.39%)
2026-03-042026-06-05
News · 26 weeks190%
2025-12-142026-06-07
Mix1590d
- SEC Filings7(47%)
- Insider4(27%)
- Earnings3(20%)
- Other1(7%)
Latest news
25 items- SECSEC Form DEFA14A filed by Ultralife CorporationDEFA14A - ULTRALIFE CORP (0000875657) (Filer)
- SECSEC Form DEF 14A filed by Ultralife CorporationDEF 14A - ULTRALIFE CORP (0000875657) (Filer)
- SECSEC Form SD filed by Ultralife CorporationSD - ULTRALIFE CORP (0000875657) (Filer)
- INSIDERDirector Whitmore Bradford T bought $715,314 worth of shares (108,878 units at $6.57) (SEC Form 4)4 - ULTRALIFE CORP (0000875657) (Issuer)
- INSIDERPresident and CEO Manna Michael Edward bought $12,939 worth of Ultralife Common Stock; $.10 par value (2,000 units at $6.47), increasing direct ownership by 7% to 28,674 units (SEC Form 4)4 - ULTRALIFE CORP (0000875657) (Issuer)
- SECSEC Form 10-Q filed by Ultralife Corporation10-Q - ULTRALIFE CORP (0000875657) (Filer)
- SECUltralife Corporation filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits8-K - ULTRALIFE CORP (0000875657) (Filer)
- PRUltralife Corporation Reports First Quarter ResultsNEWARK, N.Y., May 08, 2026 (GLOBE NEWSWIRE) -- Ultralife Corporation (NASDAQ:ULBI) reported operating results for the first quarter ended March 31, 2026 as follows: Sales of $47.4 million compared to $50.7 million for the 2025 first quarterGross profit of $10.1 million, or 21.3% of revenue, compared to $12.7 million, or 25.1% of revenue, for the 2025 first quarterOperating (loss) of ($.2) million, including one-time costs of $1.7 million, compared to income of $3.4 million for the 2025 first quarterGAAP EPS of ($0.03) compared to $0.11 for the 2025 first quarterAdjusted EBITDA of $3.2 million compared to $5.4 million for the 2025 first quarterBacklog of $115.1 million compared to $110.2 m
- PRUltralife Corporation to Report First Quarter Results on May 8, 2026NEWARK, N.Y., May 01, 2026 (GLOBE NEWSWIRE) -- Ultralife Corporation (NASDAQ:ULBI) will report its first quarter results for the period ended March 31, 2026 before the market opens on Friday, May 8, 2026. Ultralife's Management will also host an investor conference call and simultaneous webcast at 8:30 AM ET on May 8, 2026. Please see the call-in procedures which follow below. NOTE TO THOSE PLANNING TO PARTICIPATE BY PHONE: To ensure a fast and reliable connection to our investor conference call, we require participants dialing in by phone to pre-register using this link prior to the call: https://register-conf.media-server.com/register/BIa05f373879a942b691466d052a5da3ae. This will elim
- SECAmendment: SEC Form 10-K/A filed by Ultralife Corporation10-K/A - ULTRALIFE CORP (0000875657) (Filer)
- SECSEC Form 10-K filed by Ultralife Corporation10-K - ULTRALIFE CORP (0000875657) (Filer)
- INSIDERDirector Whitmore Bradford T bought $1,196,909 worth of shares (187,512 units at $6.38) (SEC Form 4)4 - ULTRALIFE CORP (0000875657) (Issuer)
- INSIDERPresident and CEO Manna Michael Edward bought $12,024 worth of Ultralife Common Stock; $.10 par value (2,000 units at $6.01), increasing direct ownership by 8% to 26,874 units (SEC Form 4)4 - ULTRALIFE CORP (0000875657) (Issuer)
- SECUltralife Corporation filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits8-K - ULTRALIFE CORP (0000875657) (Filer)
- PRUltralife Corporation Reports Fourth Quarter ResultsNEWARK, N.Y., March 10, 2026 (GLOBE NEWSWIRE) -- Ultralife Corporation (NASDAQ:ULBI) reported operating results for the fourth quarter and full year ended December 31, 2025 as follows: Fourth Quarter: Sales of $48.5 million compared to $43.9 million for the 2024 fourth quarterGross profit of $12.1 million, or 24.9% of revenue, compared to $10.6 million, or 24.2% of revenue, for the 2024 fourth quarterOperating (loss) income of ($10.6) million, which includes a ($12.2) million intangible asset impairment charge and ($1.2) million of one-time costs, compared to $1.5 million for the 2024 fourth quarterGAAP EPS of ($0.45), which includes ($0.57) for the intangible asset impairment charge net
- PRUltralife Corporation to Report Fourth Quarter Results on March 10, 2026NEWARK, N.Y., March 05, 2026 (GLOBE NEWSWIRE) -- Ultralife Corporation (NASDAQ:ULBI) will report its fourth quarter results for the period ending December 31, 2025 before the market opens on Tuesday, March 10, 2026. Ultralife's Management will also host an investor conference call and simultaneous webcast at 8:30 AM ET on March 10, 2026. Please see the call-in procedures which follow below. NOTE TO THOSE PLANNING TO PARTICIPATE BY PHONE: To ensure a fast and reliable connection to our investor conference call, we require participants dialing in by phone to pre-register using this link prior to the call: https://register-conf.media-server.com/register/BIf9df949a927a4356820e8cfb1becccdc.
- INSIDERSEC Form 4 filed by Director Whitmore Bradford T4 - ULTRALIFE CORP (0000875657) (Issuer)
- INSIDERDirector Whitmore Bradford T bought $300,902 worth of shares (53,000 units at $5.68) (SEC Form 4)4 - ULTRALIFE CORP (0000875657) (Issuer)
- INSIDERDirector Goddard Janie bought $9,999 worth of Common Stock; $.10 par value (1,739 units at $5.75), increasing direct ownership by 29% to 7,668 units (SEC Form 4)4 - ULTRALIFE CORP (0000875657) (Issuer)
- INSIDERDirector Robert W. Shaw bought $9,922 worth of Common Stock; $.10 par value (1,750 units at $5.67), increasing direct ownership by 3% to 71,000 units (SEC Form 4)4 - ULTRALIFE CORP (0000875657) (Issuer)
- INSIDERDirector Whitmore Bradford T bought $267,915 worth of shares (53,900 units at $4.97) (SEC Form 4)4 - ULTRALIFE CORP (0000875657) (Issuer)
- INSIDERPresident and CEO Manna Michael Edward bought $9,933 worth of Common Stock; $.10 par value (2,000 units at $4.97), increasing direct ownership by 9% to 24,874 units (SEC Form 4)4 - ULTRALIFE CORP (0000875657) (Issuer)
- SECUltralife Corporation filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits8-K - ULTRALIFE CORP (0000875657) (Filer)
- PRUltralife Corporation Reports Third Quarter ResultsNEWARK, N.Y., Nov. 18, 2025 (GLOBE NEWSWIRE) -- Ultralife Corporation (NASDAQ:ULBI) reported operating results for the third quarter ended September 30, 2025 with the following results: Sales of $43.4 million increased 21.5% from $35.7 million for the third quarter of 2024; excluding Electrochem, sales of $36.6 million increased 2.5%Gross profit of $9.6 million, or 22.2% of revenue, compared to $8.7 million, or 24.3% of revenue, for the third quarter of 2024Operating loss of $1.0 million, reflecting one-time non-recurring costs of $1.1 million, including a $.5 million provision to close our Calgary facility, compared to operating income of $0.5 million for the third quarter of 2024GAAP EP
- SECSEC Form 10-Q filed by Ultralife Corporation10-Q - ULTRALIFE CORP (0000875657) (Filer)
ULBI FAQ
6 questionsWhat does Ultralife Corporation do?
Ultralife Corporation, together with its subsidiaries, designs, manufactures, installs, and maintains power, and communication and electronics systems worldwide. The company serves government, defense, and commercial sectors. The company operates in two segments, Battery & Energy Products and Communications Systems. The Battery & Energy Products segment offers lithium 9-volt, cylindrical, thin lithium manganese dioxide, rechargeable, and other non-rechargeable batteries; lithium-ion cells, multi-kilowatt module lithium ion battery systems, and uninterruptable power supplies; and rugged...Where does ULBI stock trade?
Ultralife Corporation (ULBI) is listed on NASDAQ.What sector and industry is ULBI in?
Ultralife Corporation operates in the Miscellaneous sector, Industrial Machinery/Components industry.When did Ultralife Corporation go public?
Ultralife Corporation (ULBI) completed its IPO in 1992.What companies are similar to ULBI?
Notable peers in the same industry include ASML (ASML Holding N.V. New York Registry Shares), LRCX (Lam Research Corporation), TMO (Thermo Fisher Scientific Inc), DE (Deere & Company), ETN (Eaton Corporation PLC). Compare ULBI side-by-side with any of them on Quantisnow.How can I track ULBI on Quantisnow?
Quantisnow aggregates Ultralife Corporation's SEC filings, analyst ratings, insider transactions, FDA approvals, and press releases the moment they hit the wire (Wall Street's wire, on your screen.). Follow ULBI to receive live email and push alerts on every new disclosure.